Keyphrases
Postsurgical
100%
Abciximab
100%
Carotid Stenting
100%
Carotid Restenosis
100%
Recurrent Stenosis
75%
Carotid Artery Stenosis
50%
Luminal Diameter
50%
Bleeding
25%
Bolus
25%
Vascular Complications
25%
Embolic Event
25%
Ischemic Events
25%
Revascularization
25%
Restenosis
25%
Balloon Angioplasty
25%
Ischaemic Episode
25%
Stent
25%
Percutaneous Revascularization
25%
Residual Stenosis
25%
Continuous Infusion
25%
Surveillance Studies
25%
Peripheral Vascular
25%
Internal Carotid Artery
25%
Glycoprotein IIb/IIIa Inhibitors
25%
Studying up
25%
Cerebral Ischemic Stroke
25%
Duplex Surveillance
25%
Strecker
25%
Wallstent
25%
Stented Arteries
25%
Medicine and Dentistry
Stenosis
100%
Restenosis
100%
Carotid Artery Stenting
100%
Abciximab
100%
Carotid Artery Stenosis
50%
Internal Carotid Artery
50%
Bleeding
25%
Revascularization
25%
Percutaneous Transluminal Angioplasty
25%
Stenting
25%
Receptor Antagonist
25%
Continuous Infusion
25%
Fibrinogen Receptor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Stenosis
100%
Restenosis
100%
Abciximab
100%
Carotid Artery Obstruction
50%
Receptor Antagonist
25%
Bleeding
25%
Fibrinogen Receptor
25%
Neuroscience
Stenosis
100%
Abciximab
100%
Internal Carotid Artery
33%
Receptor Antagonist
16%
Fibrinogen Receptor
16%